Skip to main content
Medicina logoLink to Medicina
editorial
. 2022 Dec 3;58(12):1781. doi: 10.3390/medicina58121781

Introduction to the Special Issue—Cardiothoracic Surgical Critical Care: A Future of Distinction

Amar M Bhatt 1,*, Michael K Essandoh 2
PMCID: PMC9780926  PMID: 36556983

Critical care after cardiothoracic surgery is an inseparable component of any successful surgical program addressing intrathoracic pathologies, including heart failure treatment with mechanical circulatory support, and respiratory failure requiring extracorporeal membrane oxygenation (ECMO) therapy [1]. However, the importance of cardiothoracic surgical critical care is often omitted in conversations concerning history, present issues, or the future of intensive care medicine and cardiothoracic surgery. The coronavirus 2019 (COVID-19) pandemic brought cardiothoracic surgeons and intensivists to the forefront with heroic efforts implementing ECMO support and lung transplantation in the most severe cases [2,3]. The two-year marathon concluded with thousands of ECMO runs and hundreds of lung transplantations around the globe, resulting in incalculable benefits of lives saved. Moreover, innovations in care delivery, systems development, and network expansions happened almost overnight, with resulting structures serving communities for years to come [4,5,6]. The COVID-19 pandemic illustrated the unique expertise and importance of cardiothoracic surgical critical care for the local and nationwide communities.

Although successful, more work remains to be done to grow and expand the field of cardiothoracic surgical intensive care. It is our belief that the care provided in cardiothoracic surgical intensive care units (CT-ICUs) is unique and requires special considerations, including an appreciation of its history, training, current knowledge gaps, and future goals. In this Special Issue of Medicina, first, the history and evolution of critical care after cardiac surgery is described. Second, readers are invited to concentrate on the specific training and education required to provide patients with the best cardiothoracic critical care. Further analysis concentrates on the appraisal of current knowledge gaps in the field, followed by future goals and strategies. Finally, the issue concludes with a review of trailblazing therapy for out-of-hospital cardiac arrest, with extracorporeal cardiopulmonary resuscitation (E-CPR). We hope you have a stimulating read!

Acknowledgments

We would like to thank Ravi Tripathi for the divisional support.

Author Contributions

A.M.B. and M.K.E. wrote and revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

Funding Statement

This research received no external funding.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Sherif H.M. Cardiothoracic surgical critical care: Principles, goals and direction. Int. J. Surg. 2012;3:111–114. doi: 10.1016/j.ijsu.2012.02.007. [DOI] [PubMed] [Google Scholar]
  • 2.Barbaro R.P., MacLaren G., Boonstra P.S., Combes A., Agerstrand C., Annich G., Diaz R., Fan E., Hryniewicz K., Lorusso R., et al. Extracorporeal membrane oxygenation for COVID-19: Evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet. 2021;398:1230–1238. doi: 10.1016/S0140-6736(21)01960-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kurihara C., Manerikar A., Querrey M., Felicelli C., Yeldandi A., Garza-Castillon R., Jr., Lung K., Kim S., Ho B., Tomic R., et al. Clinical Characteristics and Outcomes of Patients With COVID-19-Associated Acute Respiratory Distress Syndrome Who Underwent Lung Transplant. JAMA. 2022;327:652–661. doi: 10.1001/jama.2022.0204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Schwartz G.S., Blough B., Monday K., Weddle R., Hebert C., Spak C., Sandkovsky U., Gottlieb R.L., Hernandez O., Lingle K., et al. Extracorporeal membrane oxygenation for COVID-19: Lessons learned. Curr. Chall. Thorac. Surg. 2021;3 doi: 10.21037/ccts-21-22. [DOI] [Google Scholar]
  • 5.Dave S., Shah A., Galvagno S., George K., Menne A.R., Haase D.J., McCormick B., Rector R., Dahi S., Madathil R.J., et al. A Dedicated Veno-Venous Extracorporeal Membrane Oxygenation Unit during a Respiratory Pandemic: Lessons Learned from COVID-19 Part I: System Planning and Care Teams. Membranes. 2021;11:258. doi: 10.3390/membranes11040258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Brodie D., Abrams D., MacLaren G., Brown C.E., Evans L., Barbaro R.P., Calfee C.S., Hough C.L., Fowles J.A., Karagiannidis C., et al. Extracorporeal Membrane Oxygenation during Respiratory Pandemics: Past, Present, and Future. Am. J. Respir. Crit. Care. Med. 2022;205:1382–1390. doi: 10.1164/rccm.202111-2661CP. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicina are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES